31 C
Vientiane
Tuesday, June 3, 2025
spot_img
Home Blog Page 18

BLUETTI and Footprint Project Forge Partnership to Bring Essential Clean Power Lifelines to Storm-Hit Communities

LAS VEGAS, May 31, 2025 /PRNewswire/ — BLUETTI, a global leader in clean energy solutions, today announced a strategic partnership with the non-profit organization Footprint Project to tackle the upcoming hurricane and storm season head-on.

The Footprint Project tests BLUETTI home battery backups and solar generators to ensure a swift and reliable response in disaster relief efforts.
The Footprint Project tests BLUETTI home battery backups and solar generators to ensure a swift and reliable response in disaster relief efforts.

Driven by its ESG commitment, BLUETTI is donating $50,024 worth of clean energy products—including the EP500 Pro, Elite 200 V2, AC200L, AC180P and 350W solar panels—to provide timely power support for disaster-affected communities. Recognizing the annual threat of grid-disrupting hurricanes like 2024’s Helene, this partnership leverages Footprint Project’s expertise in delivering clean energy since 2018 to swiftly deploy BLUETTI’s tailored solutions to vulnerable areas like the U.S. Gulf Coast, directly aiding emergency response and recovery.

Powering the Frontline Relief

Drawing on over 25 disaster missions, Footprint Project understands that effective frontline relief requires agile power. The Elite 200 V2 Solar Generator offers this with its portable yet versatile design. Its durable automotive-grade LiFePO₄ battery ensures up to 17 years of safe and reliable energy. Featuring nine versatile outlets and a robust 3900W surge capacity, it can simultaneously power vital communication devices, rechargeable tools like drills and saws for debris clearing or emergency repairs, and critical small medical equipment such as CPAP machines and oxygen concentrators.

Complementing this, highly acclaimed units like the AC200L and AC180P Solar Generator also provide essential power for items such as small fans to improve comfort and lighting to support nighttime rescue efforts. All these units can be rapidly recharged using the 350W Solar Panel, which features a user-friendly design for quick, simple deployment in any sunny location, providing a rapid and reliable energy refill for all units on the frontline.

Powering the Crisis Hub

As hurricanes strike and linger, the Footprint Project swiftly establishes vital “resource hubs”—islands of safety and power until the grid revives. Central to this will be the EP500 Pro Home Battery Backup, its 5120Wh capacity fueling days of essential operations. Its robust 3000W and 15 outlets power everything from continuous safety lighting and critical cold storage for life-saving medicines like insulin and vaccines, to vital communication and reconnaissance drones, all easily deployed on smooth-rolling wheels to wherever power is needed most, transforming vulnerability into a secure, functioning community powered by clean energy.

Powering Hope and Resilience

“Storms remind us of our shared need for power, a core value at BLUETTI,” said James Ray, Brand Representative at BLUETTI. “Our partnership with Footprint Project in delivering clean energy aid is a natural fit, and we hope our power solutions offer real comfort – which is the very essence of our home battery backup.”

Echoing this sentiment, Jamie Swezey, Program Director for Footprint Project, said, “We’re thrilled to collaborate with BLUETTI in delivering sustainable response technology to communities impacted by disasters. Thanks to their equipment commitment, we can expand our outreach and more effectively support communities facing climate emergencies.”

This partnership highlights the shared mission of BLUETTI and Footprint Project to deliver reliable clean energy precisely where it’s needed most—proactively before, urgently during, and sustainably after disasters. By supporting communities on the front lines of climate emergencies, both organizations not only strengthen disaster response but also play a crucial role in ensuring families are better equipped for the challenges ahead, while advocating for greater hurricane preparedness across vulnerable regions.

About BLUETTI

As a technology pioneer in clean energy, BLUETTI is committed to delivering reliable, sustainable power where it’s needed most—especially during extreme weather and emergencies. Through social impact initiatives such as the LAAF (Lighting An African Family) program, BLUETTI brings clean energy solutions to underserved communities. Rooted in ESG principles, BLUETTI continues to lead with innovation and practical solutions, earning trust across more than 110 countries and regions.

About Footprint Project

Footprint Project provides renewable energy equipment and training to communities affected by climate disasters and humanitarian crises. Footprint Project develops and deploys mobile solar microgrid networks in climate-vulnerable regions to support critical services during power outage events and trains local responders on effective use. As a 501(c)(3) nonprofit service organization, their mission is to help build back greener after climate disasters by providing cleaner energy infrastructure to communities in crisis.

Media Contact 
Ellen Lee
PR Specialist
ellenlee@bluetti.com

 

/C O R R E C T I O N — Progold S.p.A./

A new phase of strategic expansion in Asia

VICENZA, Italy, May 30, 2025 /PRNewswire/ — Progold S.p.A., an Italian company based in Trissino (Vicenza) and a global leader in the development and production of precious metal alloys and advanced additive technologies for the jewellery industry, announces the acquisition of 100% of the share capital of ABI Manufacturing International Ltd, a Bangkok-based company operating in the same sector.

This transaction marks a key strategic step for Progold, strengthening its presence in the high-potential region of Asia, with the goal of consolidating the Group’s global leadership in the field of precious metal alloys and additive technologies for jewellery manufacturing.

The acquisition aims not only to reinforce Progold’s commercial presence in the Asian market but also to enhance strategic relationships with leading Asian players in the industry, accelerating the implementation of the Group’s industrial plans and opening up new growth opportunities.

ABI Manufacturing International Ltd, a historic U.S. brand founded by Gary Ford, will continue to operate under its own brand and organizational structure, benefiting from integration with Progold’s technological expertise, financial resources, and innovative capabilities. Operational management will remain under the leadership of current CEO Nongluck Julsuwan and COO Noppadon Niwattannan, ensuring strategic continuity. The Board of Directors will be expanded to include Damiano Zito, President and CEO of Progold, Gemma Michelin, Deputy CEO of Progold, and Thomas Hammershøy Nyborg, Board Member of Progold.

The acquisition has been actively supported by LBO France, a pioneer in private equity in France and a multi-specialist, multi-country investment platform. Active in the sectors of Private Equity, Real Estate, Venture Capital, and listed markets, LBO France has in recent years expanded its activity across Europe—particularly in Italy through Polis SGR—and into Africa via its subsidiary CGF Bourse. LBO France is one of the founding member of the international climate initiative and one of the first signatories of the France Invest Gender Equality Charter. Since December 2021, Progold S.p.A. has been backed by LBO France through the Small Caps Opportunities fund.

With this transaction, Progold S.p.A. takes a decisive step in its international growth journey, combining strategic vision, industrial excellence, and technological innovation.

Advisors involved in the transaction:

Chandler Mori Hamada Limited 
PWC 
Tilleke & Gibbins 
Greenberg Glusker LLP 
Advant NCTM 
Kroll Associates S.r.l.
Ramboll Italy S.r.l.   

From left to right: CEO di ABI Nongluck Julsuwan, Chairman & CEO di Progold Damiano Zito, founder di ABI Gary Ford, COO Noppadon Niwattannan.
From left to right: CEO di ABI Nongluck Julsuwan, Chairman & CEO di Progold Damiano Zito, founder di ABI Gary Ford, COO Noppadon Niwattannan.

 

From left to right: CEO di ABI Nongluck Julsuwan, CEO di Progold Gemma Michelin, founder di ABI Gary Ford, COO Noppadon Niwattannan.
From left to right: CEO di ABI Nongluck Julsuwan, CEO di Progold Gemma Michelin, founder di ABI Gary Ford, COO Noppadon Niwattannan.

 

SuperMaker AI Launches Free AI Video Platform That Actually Works

SHERIDAN, Wyo., May 30, 2025 /PRNewswire/ — Here’s something cool. SuperMaker AI just dropped a new platform that lets anyone make professional videos.
And get this – you don’t need to sign up to try it.

Four AI Tools, One Platform

The platform packs four AI tools into one place.
There’s an AI video maker. An AI image creator. A music creator. And a voice generator.
Pretty much everything you need to make a video.

Want to turn text into a video? Done.
Got a photo you want to animate? Easy.
Need a voiceover in different languages? No problem.
The platform handles it all.

Here’s How It Works

You can start using it right away.
No email required.
No credit card needed.
Just go to the website and start creating.

Sign up later and they’ll give you bonus credits.
When those run out, you can subscribe for more.
But the free trial gives you a real taste of what it can do.

The video quality is surprisingly good.
We’re talking cinema-grade stuff, not some pixelated mess.
The AI keeps characters looking consistent throughout the video.
That’s been a big problem with other platforms.

Why This Matters

Most AI video tools either cost a fortune or produce garbage.
SuperMaker AI is trying to change that.
They want everyone to have access to professional creation tools.

The platform is live now at https://supermaker.ai/.
No waiting lists. No beta invites. Just go and try it.

The Bottom Line

  1. Free to start – Use it without signing up
  2. Actually good quality – Cinema-grade video output
  3. Everything included – Video, images, music, voice in one place
  4. Simple to use – No tech skills needed
  5. Fair pricing – Try free, pay only if you want more

SuperMaker AI thinks everyone should be able to make great content.
Based on what we’ve seen, they might be onto something.

About SuperMaker AI

SuperMaker AI makes AI creation tools that actually work.
Visit https://supermaker.ai/ to try it yourself.

The World Debt Situation Has Become More Unstable, Octa Broker warns


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 30 May 2025 – Traders and investors alike are unnerved by the recent turbulence in the bond markets. After Moody’s—a major rating agency—downgraded U.S. government debt on 16 May, and Japanese long-term bond yields soared to multi-decade highs, some market participants started to fear that the world may be on the verge of a major debt crisis. Meanwhile, the yield on 20-year UK government bonds neared 5.5%, a level not seen in 27 years, as investors grew more worried about the extent of Chancellor Rachel Reeves’ borrowing plans. Octa Brokers looks at the potential implications of these developments for global markets.

Octa Broker


Ticking Fiscal Bomb

The U.S. mounting national debt has long been the subject of intense debate and concern among economists, policymakers, and the public. Apocalyptic predictions of a U.S. default and dollar collapse are nothing new. They first appeared decades ago and have been surfacing here and there regularly, attracting plenty of followers. However, these predictions have never materialised, while the doomsayers have been dismissed as amateur conspiracy theorists at best and irresponsible alarmists at worst. Still, while we are not inclined to take a grand stance on this issue, we cannot afford to ignore the latest market developments regarding the U.S. debt. Often called a ‘ticking fiscal bomb’, it has recently started raising fears about the nation’s long-term economic stability and potential impact on global markets.

‘On current trends, U.S. national debt is projected to reach $37 trillion in two weeks and may reach $40 trillion by the end of the year. This trend cannot continue forever. The Fed’s [Federal Reserve] printing press may have no limit, but market patience does have its limit’, says Kar Yong Ang, a financial market analyst at Octa broker.

Indeed, the market’s perception of risk regarding U.S. government debt has clearly risen. This is evident in the noticeable increase in the cost of insuring exposure to U.S. government debt over the past month. The spreads on U.S. credit default swaps (CDS)—a key measure of default risk—have reached their widest levels since the 2023 debt ceiling crisis in recent weeks (see chart below).

Market stress intensified even more following Moody’s downgrade and the passage of the U.S. President Donald Trump’s ‘One Big Beautiful Bill Act’ in the House of Representatives. The bill features $3.8 trillion in tax cuts and is widely expected to worsen the federal budget deficit outlook. As a result, investors started to demand higher returns for holding long-term U.S. government bonds, pushing the yields on 20-year notes above the important 5% level on 21 May.

5-Year Credit Default Swaps

Source: LSEG
Source: LSEG

Kar Yong Ang comments: ‘Policy uncertainty is all over the place. Tariffs, tax bill, debt ceiling. No wonder investors charge a premium for holding the debt of a country, which is not in a ‘triple-A club’ anymore. Investors want higher yield in order to provide long-term lending in the current uncertain climate’.

Indeed, the U.S. government actually hit its legal borrowing limit back in January and has been using special procedures to avoid exceeding it and potentially defaulting. However, these measures are expected to run out around late August or early September, at which point the government might be unable to meet all its financial commitments.

Yields of government bonds with the longest maturities have been rising sharply not just in the United States but also in Japan and the United Kingdom (UK) (see chart below). On 20 May, Japan’s 20-year government bond (JGB) auction had its worst results since 2012. The demand was weak, with the bid-to-cover ratio dropping to 2.50, while the lowest accepted price was just ¥98.15, some 2% below the expected price.

Yields on 20-Year Government Bonds
Source: LSEG
Source: LSEG

‘Japan’s auction signals poor liquidity and weak interest in new long-term securities as investors are concerned about excessive profligacy. It seems to me that the BoJ wants to stop buying bonds at the worst possible moment. Who is going to replace it?’, rhetorically asks Kar Yong Ang, referring to BoJ plans to taper its massive bond purchase programme.

Indeed, although yields on long-term JGBs have been rising since the COVID pandemic, the trend accelerated after the Bank of Japan (BoJ) moved toward monetary policy normalisation amid rising wage growth and inflation. Policy normalisation implied higher short-term rates and fewer bond purchases. Thus far, BoJ has ended its yield curve control (YCC), raised its benchmark interest rate from -0.1% to 0.5% and even embarked on quantitative tightening (QT). These factors contributed to the consistent increase in Japanese government bond yields. Today, however, the situation is complicated by additional fiscal stimulus, which could result in more government borrowing just as the BoJ prepares to slowly exit the debt markets. The Cabinet already approved a massive ¥21.9 trillion ($142 billion) economic stimulus package back in November 2024. Most recently, it approved an emergency plan to allocate ¥388 billion ($2.7 billion) from reserve funds to assist businesses and households affected by U.S. tariffs.

‘Investors are sending a very clear message: if we are the only ones left to finance these spending plans, then we demand higher returns’, concludes Kar Yong Ang.

The recent movements in the U.S., Japanese, and UK government bond markets paint a concerning picture of increasing investor unease regarding sovereign debt. From the rising cost of insuring U.S. debt and the poor reception of Japan’s long-term bond auction to the near 27-year high in the UK gilt yields, a common thread of heightened risk perception is evident. As Kar Yong Ang of Octa Broker points out, factors like policy uncertainty, fiscal profligacy, and the prospect of central banks reducing their bond purchases are prompting investors to demand greater compensation for lending to governments.

‘The problem is not just that governments have an enormous mountain of debt. The real problem is that the market is intricately interconnected. A small trouble in one place can morph into a major crisis elsewhere. What if higher JGB yields lure Japanese capital back home? If they decide to increase their JGB holdings, they may have to sell the U.S. Treasuries and that could be catastrophic given that Japan is a major holder of U.S. debt’, says Kar Yong Ang.

Investors should watch the upcoming BoJ meeting scheduled for 17 June. The BoJ will issue its regular policy rate decision and will likely announce its balance sheet reduction plan. According to MacroMicro, markets currently expect a gradual pace—around 6–7% reduction over two years. However, if the BoJ opts to speed up the process, it could put pressure on global markets

___

Disclaimer: This content is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to engage in any investment activity. It does not take into account your investment objectives, financial situation, or individual needs. Any action you take based on this content is at your sole discretion and risk. Octa and its affiliates accept no liability for any losses or consequences resulting from reliance on this material.
Trading involves risks and may not be suitable for all investors. Use your expertise wisely and evaluate all associated risks before making an investment decision. Past performance is not a reliable indicator of future results.
Availability of products and services may vary by jurisdiction. Please ensure compliance with your local laws before accessing them.
Hashtag: #Octa

The issuer is solely responsible for the content of this announcement.

Octa

is an international CFD broker that has been providing online trading services worldwide since 2011. It offers commission-free access to financial markets and various services used by clients from 180 countries who have opened more than 52 million trading accounts. To help its clients reach their investment goals, Octa offers free educational webinars, articles, and analytical tools.

The company is involved in a comprehensive network of charitable and humanitarian initiatives, including improving educational infrastructure and funding short-notice relief projects to support local communities.

In Southeast Asia, Octa received the ‘Best Trading Platform Malaysia 2024’ and the ‘Most Reliable Broker Asia 2023’ awards from Brands and Business Magazine and International Global Forex Awards, respectively.

HH Chemical Launches BIODEX® — The World’s First Fully Integrated Bio-Based Materials Brand Tackling Multi-Industry Challenges Through Innovation

SINGAPORE, May 30, 2025 /PRNewswire/ — HH Chemical has officially launched BIODEX®, the world’s first bio-based materials brand offering a fully integrated solution across the entire value chain—from renewable raw materials to finished consumer products. This breakthrough platform establishes a closed-loop ecosystem, enabling seamless integration from green sourcing to end-use applications.

The BIODEX® product portfolio spans high-performance monomers, elastomers, polymer chips, fibers, functional fabrics, and customizable garments—empowering industries to pursue a future where sustainability and performance go hand in hand.

With three defining advantages—greener, softer, and more elastic — BIODEX® supports a wide range of applications across textiles and apparel, automotive, aerospace, personal care, and biomedical sectors. The brand introduces a new era of sustainable living that balances advanced functionality with elevated aesthetics, helping accelerate the global transition toward greener manufacturing and healthier consumption.

Next-Generation Performance with Verified Environmental Gains

BIODEX® outperforms conventional synthetic fibers in softness, elasticity, breathability, and shape retention—while delivering a dramatic environmental advantage. Compared to petroleum-based nylon polymers, BIODEX® reduces carbon emissions by up to 73% during production and is fully recyclable at the end of its lifecycle, establishing a new industry benchmark for balancing performance with sustainability.

“The launch of BIODEX® represents a major breakthrough in bio-based materials science and reflects our deep commitment to global consumer well-being and environmental stewardship under the ESG framework,” said Leo Wang, Co-Founder and General Manager of HH Chemical, in an interview with the Singapore Economic Development Board.

Advancing Material Solutions for Complex, Long-Standing Needs

BIODEX® is already disrupting traditional product categories through material innovation. For instance, conventional foam used in women’s lingerie and swimwear has long posed health and environmental concerns due to potential toxic emissions during manufacturing and disposal. BIODEX® offers a safer, more breathable, fully recyclable, and cost-efficient alternative—designed for women of all skin tones and cultural backgrounds seeking comfort without compromise.

Bridging the Lab-to-Market Gap Through Global Scientific Collaboration

BIODEX® was developed through a joint research initiative between HH Chemical and the National University of Singapore (NUS), under the SINERGY (Singapore Consortium for Synthetic Biology). Leveraging palm oil byproducts and HH Chemical’s proprietary biosynthesis platform, the BIODEX® series was patented and scaled for commercial production in 2023.

Now, BIODEX® is expanding into high-value segments including healthcare, sustainablepackaging, and eco-industrial materials, aligning with the global circular economy and empowering partners to transform their product portfolios through green innovation.

As global momentum toward carbon neutrality intensifies, BIODEX® aims to serve as a catalyst for change—connecting research, manufacturing, and consumer ecosystems through material science to drive a more efficient, sustainable, and environmentally responsible future.

About HH Chemical

HH Chemical is a global leader in bio-based materials innovation. The company offers end-to-end capabilities across the bio-based value chain—from monomer and polymer R&D and manufacturing to commercial applications and ESG-driven solutions. Its proprietary PDO (1,3- Propanediol) and PTT (polytrimethylene terephthalate) platforms are fully commercialized and deployed at scale.

Website: www.biodexsg.com

dancemoon Reinvents Itself with Its First Bathroom Essential: the JustHang Squeegee

NEW YORK, May 30, 2025 /PRNewswire/ — dancemoon, the trailblazer in home cleaning innovation, is excited to announce the launch of its first bathroom essential product: the dancemoon JustHang Squeegee. The product will be available for pre-order in the US starting May 30 on the brand’s official website and Amazon, with global availability beginning in June.


dancemoon JustHang Squeegee

Bathroom glass never stays clean. Why bother with such tedious chores? This honest complaint sparked a new journey for the dancemoon team. Well aware of users’ frustrations with streaky blades, falling hooks and cracked handles, the dancemoon designer asked a simple but powerful question: What if a squeegee could keep the bathroom spotless and serve as a hook itself?

dancemoon tested a wide range of silicone formulations before perfecting a one-piece blade that glides effortlessly and removes all water without leaving streaks or scratching the glass. A large built-in hook enables convenient storage anywhere in the bathroom, maintaining a clean and organized space without drilling or suction cups.

The JustHang Squeegee is designed as a well-considered solution to everyday cleaning frustrations, offering a versatile all-in-one cleaning experience. It features an ergonomic anti-slip handle, enhanced performance, and an innovative integrated storage design, redefining both the efficiency and aesthetics of home cleaning.

Highlights:

  • Streak-Free Performance: High-efficiency silicone blade ensures a streak-free finish with every swipe, leaving the glass crystal clear and squeak-free.
  • Versatile Built-in Hook Design: Designed with a large hook at the tail, allowing for easy hanging without the need for additional hooks.
  • Ergonomic Anti-Slip Handle: Crafted with premium rubber, the ergonomic handle ensures a comfortable, anti-slip grip even in wet conditions.
  • Seamless Silicone Construction: The seamless silicone design offers a sleek and minimalist look that complements modern aesthetics and prevents dirt buildup for easier cleaning.
  • Durable and Sturdy: Made from high-quality, durable floor-friendly materials, ensures exceptional performance even with long-term use.

With the launch of its first bathroom essential product, dancemoon expands its dedication from pet care to innovative home cleaning solutions. dancemoon remains committed to providing high-quality, thoughtfully designed products for every home. This transition reflects the brand’s dedication to enhancing the quality of life, offering customers a seamless, elevated living experience through innovative design.

To place an order, please visit dancemoon’s Amazon store and Shopify.

Or follow dancemoon on social media to stay updated with the latest campaigns for the new product:

TikTok: https://www.tiktok.com/@dancemoon.official 
Instagram: https://www.instagram.com/dancemoon.global/ 
Facebook: https://www.facebook.com/dancemoonofficial 
YouTube: https://www.youtube.com/@dancemoonofficial 

About dancemoon

Driven by a passion for innovative design, dancemoon infuses the beauty and emotion of the moon into each product. Beyond offering household tools, dancemoon combines innovation with minimalist design to create products that make household tasks simple and no longer a burden but an enjoyable part of life. With a vision to become the leading brand of minimalist lifestyle, dancemoon is committed to blending minimalism with household tools, bringing bliss into your daily life.

CONTACT: info@dancemoon.com

Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG)

SHANGHAI, May 30, 2025 /PRNewswire/ — Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by its wholly-owned subsidiary T-mab has officially obtained the marketing approval by National Medical Products Administration (NMPA). MAILISHENG is Mabwell’s first commercialized innovative drug, and is the first launched novel granulocyte colony-stimulating factor (G-CSF) developed with albumin long-acting fusion technology in China.

Albipagrastim alfa for Injection is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.

Albipagrastim alfa is a new generation of long-acting G-CSF (highly active modified cytokine) with intellectual property rights of Mabwell, which was developed with albumin fusion platform technology by fusing highly active recombinant G-CSF with human serum albumin (HSA). The modification increases the molecular weight, significantly inhibits the elimination pathway mediated by G-CSF receptor and prolongs the half-life of the drug in vivo, which improves the treatment adherence by reducing the frequency of administration in clinical practice. Compared to PEG-G-CSF, Albipagrastim alfa uses HSA as its natural carrier protein via a Pichia pastoris expression system. This approach offers a simpler production process and superior product homogeneity.

Mabwell previously presented results from a Phase III clinical study of 8MW0511 at the European Society for Medical Oncology (ESMO) annual meeting in 2023, and the full manuscript was published in May 2025 in Breast Cancer Research. 496 patients with breast cancer were enrolled and randomized into the study (8MW0511, n=331, control group, n=165). The result of study showed that 8MW0511 was clinically effective, non-inferior to the positive control. It is able to reduce the incidence of grade 4 neutropenia, significantly shorten the duration of grade 4 neutropenia and lower the incidence of Febrile Neutropenia (FN). The overall safety profile is similar to that of the positive control group, which indicates manageable safety profile and good tolerance in humans. The 8MW0511 group was superior to the control group in terms of the incidence of grade 4 neutropenia in cycle 1-4 of chemotherapy, the duration of grade 4 neutropenia, and the incidence of febrile neutropenia. Compared with the control group, the Absolute Risk Reduction (ARR) of grade 4 neutropenia was 3.1%, 7.0%, 4.2%, and 2.8%, while the Relative Risk Reduction (RRR) of grade 4 neutropenia was 15.6%, 68.4%, 58.3% in the 8MW0511 group during the cycle 1-4 of chemotherapy. RRR of FN was 42.0% [1]. The results of this study suggest that 8MW0511 has clinical advantages over the positive control drug, and safety advantages as a long-acting molecule using natural human proteins.

The phase III clinical trial of 8MW0511 also included a chemotherapy regimen of TAC (docetaxel, doxorubicin, and cyclophosphamide), which has a high risk of FN. Stratified analysis showed that comparing to the control group, the incidence of grade 4 neutropenia in the 8MW0511 group was slightly lower during the first cycle of chemotherapy, and significantly lower during cycle 2-4 of chemotherapy.

[1] Absolute Risk Reduction (ARR): the absolute difference in the percentage of patients who did not develop grade 4 neutropenia in the test group versus the control group. Relative Risk Reduction (RRR): the relative degree to which the risk of developing grade 4 neutropenia was reduced in the test group compared to the control group.

About Neutropenia

Neutropenia is a relatively common hematologic toxicity caused by chemotherapy with cytotoxic drugs, with studies showing that 65.5% of patients treated with chemotherapeutic agents such as paclitaxel, adriamycin, and cyclophosphamide experience a grade 3 or 4 decrease in their neutrophil counts. Febrile neutropenia (FN), as a clinical complication of chemotherapy, commonly results in prolonged hospitalization, increased use of broad-spectrum antibiotics and cost of therapy, reduction of chemotherapeutic agents or delayed chemotherapy, and ultimately affecting the efficacy of antitumor therapy. In more serious cases, it may lead to sepsis syndrome, infectious shock, and even death. Therefore, preventing or treating neutropenia and reducing the incidence of FN are fundamental to ensure adequate or dose-intensive chemotherapy.

Globally, more than 50% of new cancer cases require chemotherapy. The number of new tumor cases in 2025 is expected to be at 5.03 million (J Natl Cancer Cent. 2024,4(1)), and the number of patients who will require the first course of chemotherapy each year from 2018 to 2040 will increase from 9.8 million (corresponding to about 50 million chemotherapy cycles) to 15 million (corresponding to about 75 million chemotherapy cycles), i.e. an increase of 53%, according to an article published in the journal The Lancet Oncology. By 2040, more than 57.7% of cancer patients worldwide are expected to require chemotherapy. In addition, with the in-depth development of basic, translational and clinical oncology research, more individualized oncology treatment, and emergence of new antitumor therapeutics, drugs for the prevention or treatment of neutropenia hold great promise for application.

About Mabwell

Mabwell (688062.SH) is an innovation-driven biopharmaceutical company with the entire value chain of the pharmaceutical industry. We provide more effective and accessible therapy and innovative medicines to fulfill global medical needs. Since 2017, an advanced R&D system which covers target discovery, early discovery, druggability, preclinical, clinical research and manufacturing transformation was established. Mabwell has 16 pipeline products in different stages based on a world-class and state-of-the-art R&D engine, including 12 novel drug candidates and 4 biosimilars. We focus on the therapeutic areas of oncology, immunology, bone disorders, ophthalmology, hematology and infectious diseases, etc. Of these, 4 products have been approved and commercialized, 1 product filed for pre-NDA meeting, 2 products are in pivotal trials. We have also undertaken 1 national major scientific and technological special project for “Significant New Drugs Development”, 2 projects for National Key R&D Programmes, and multiple provincial and municipal science and technological innovation projects. Mabwell’s Taizhou factory possesses robust in-house manufacturing capability compliant with international GMP standards regulated by the NMPA, FDA and EMA, and has passed the EU QP Audit. The large-scale manufacturing base in Shanghai and the ADC commercialized manufacturing base in Taizhou are under construction. Our mission is “Explore Life, Benefit Health” and our vision is “Innovation, from ideas to reality”. For more information, please visit www.mabwell.com/en.

Forward-Looking Statements

This press release contains forward-looking statements including, but not limited to, the potential safety, efficacy, regulatory review or approval and commercial success of our product candidates and those relating to the Company’s product development, clinical studies, clinical and regulatory milestones and timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. “Forward-looking statements” are statements that are not historical facts and involve a number of risks and uncertainties, which may cause actual results to be materially different from any future results expressed or implied in the forward-looking statements. These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential,” “predict,” “project,” “should,” “would,” and similar expressions and the negatives of those terms.

Forward-looking statements are based on the Company’s current expectations and assumptions. Forward-looking statements are subject to a number of risks, uncertainties, and other factors, many of which are beyond the Company’s control, including, but not limited to: environment; politic; economy; society; legislation; our dependence on our product candidates, most of which are still in preclinical or various stages of clinical development; our reliance on third-party vendors, such as contract research organizations and contract manufacturing organizations; the uncertainties inherent in clinical testing; our ability to complete required clinical trials for our product candidates and obtain approval from regulatory authorities for our product candidates; our ability to protect our intellectual property; the potential impact of COVID-19; the loss of any executive officers or key personnel. In case one or more of these risks or uncertainties deteriorate, or any assumptions are incorrect, the actual results may be seriously inconsistent with the stated results.

The Company cautions all the persons not to place undue reliance on any such forward-looking statements, which speaks only as of the date of this press release. The Company disclaims any obligation, except as specifically required by law and the rules of the applicable Stock authority to publicly update or revise any such statements to reflect any change in expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. All forward-looking descriptions, figures and assumptions in this press release are applicable to this statement.

Fosi Audio Debuts 1st MemberFest — Building a Unique Global HiFi Community

SHENZHEN, China, May 30, 2025 /PRNewswire/ — Fosi Audio, a brand committed to redefining high-fidelity sound with unmatched value and user-centered innovation, has officially launched its inaugural MemberFest, running from May 27 to June 8 (PST). The event celebrates the brand’s growing global community and deepens the connection between Fosi Audio and its users worldwide.

Unlike traditional promotional campaigns, its MemberFest is built on real stories, shared passions, and creative collaboration. It’s a chance for Fosi Audio and its users to shape a unique community together.

Hear the Unheard – Brand Theme Music Video Released

As an audio brand deeply connected with its users, Fosi Audio is committed not only to delivering the best possible sound quality in every device, but also to ensuring that every voice is heard—bringing warmth and meaning to sound itself. To bring this belief to life, Fosi Audio released an original theme song, Hear the Unheard, premiering at MemberFest. The music video resonated deeply with the community, earning praise and admiration for Fosi Audio’s values and brand spirit.

Real Stories, Real Voices

At the heart of this festival are the voices of Fosi members themselves. Through short videos and photo submissions, fans are sharing their journeys — from first discoveries of high-quality audio to building DIY setups with Fosi gear. These personal accounts, featured on Fosi’s official platforms, echo a common theme: the joy of connection through music and sound.

Creativity Beyond Products

In the spirit of co-creation, Fosi is inviting users to design future merchandise. Submissions from the community will be considered for limited-edition production, and selected participants will be honored as Fosi Audio Creative Masters — a title that reflects both pride and contribution to the brand’s visual identity.

Perks with Purpose

To thank its members, Fosi Audio is offering double points for all purchases made by registered members during the festival. These points can be redeemed for rewards including gift cards, discount coupons, and even free products. A spin-the-wheel game adds a layer of fun, allowing users to win mystery gifts and major deals across Fosi’s online stores.

New Product Spotlight: SP601 Passive Speakers

Coinciding with MemberFest, Fosi Audio also officially launches the SP601 passive bookshelf speakers. Designed to complement the brand’s growing lineup of amplifiers and DACs, the SP601 offers rich, natural sound. Influencers across platforms are already sharing first impressions, adding depth to the festival atmosphere.

“HiFi is more than just great sound — it’s about the people who make it meaningful. MemberFest is our way of celebrating that shared passion. Together, we’re building something truly special.” — Ryan Huang, CEO of Fosi Audio

As MemberFest continues, Fosi Audio invites everyone — music lovers, creators, tinkerers, and dreamers — to join the celebration. Because HiFi isn’t just about hearing. It’s about being heard.

Learn more and participate: https://fosiaudio.com/pages/fosi-audio-1st-memberfest

About Fosi Audio

As a global audio company, Fosi Audio places customers above all else, guided by a deep understanding of users’ needs and a commitment to co-creating with users. Fosi Audio has won sincere recognition from a wide range of audiophiles and well-known media such as Wirecutter, Trusted Reviews, Headfonia, TNT-Audio, and digitaltrends, authoritative forums like AudioScienceReview, Head-fi, and well-known HiFi enthusiasts such as Cheapaudioman, Z Reviews, and A British Audiophile, etc.

For more information, please visit: